All4NutraNo products in the cart.
All4NutraStartseite » Orally Dissolving Technology Excipient » Page 8
An important feature of orodispersible tablets (ODTs) is the convenient administration of the drugs, in some cases, faster onset of...
The purpose of the present study was to provide the experimental and theoretical basis of bioequivalence (BE) dissolution test criteria...
Since famotidine (FA) is prescribed for gastrointestinal diseases orodispersible tablets could contribute to patients’ compliance. Its bitter taste and poor...
See the fifth issue of Fuji Chemical Industries Technical Newsletter. It presents the application of F-Melt® for manufacturing oral disintegrating tablets...
Visual impairment and blindness affects 285 million people worldwide, resulting in a high public health burden. This study reports, for...
Non-compliance, dosing inaccuracy, choking risk, flavour, and instability, are some of the issues associated with paediatric, oral dosage forms —...
Abstract One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and...
Therapeutic proteins and peptides (TPPs) are increasingly favoured above small drug molecules due to their high specificity to the site...
The formulation development of amorphous solid dispersions (ASDs) towards a patient-friendly oral solid dosage form is proving to be still...
It is recognised that paediatric indications and age-appropriate formulations are required to ensure that paediatric populations receive appropriate pharmacotherapeutic treatment....
Copyright: PharmaExcipients AG